Tenax Therapeutics, Inc.TENXNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank79
3Y CAGR+31.1%
5Y CAGR+10.6%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+31.1%/yr
vs +95.3%/yr prior
5Y CAGR
+10.6%/yr
Recent acceleration
Acceleration
-64.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
20254.92+379.3%
20241.03+52.7%
20230.67-69.3%
20222.19-56.6%
20215.04+69.1%
20202.98+28.8%
20192.32+1438.7%
20180.15-100.0%
20172490.32+77747.1%
20163.20-